New insights into lipopolysaccharide inactivation mechanisms in sepsis
The complex pathophysiology of sepsis makes it a syndrome with limited therapeutic options and a high mortality rate. Gram-negative bacteria containing lipopolysaccharides (LPS) in their outer membrane correspond to the most common cause of sepsis. Since the gut is considered an important source of...
Main Authors: | Eréndira Guadalupe Pérez-Hernández, Blanca Delgado-Coello, Ismael Luna-Reyes, Jaime Mas-Oliva |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221006727 |
Similar Items
-
Orexin-A Prevents Lipopolysaccharide-Induced Neuroinflammation at the Level of the Intestinal Barrier
by: Lea Tunisi, et al.
Published: (2019-04-01) -
The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases
by: Paulraj Kanmani, et al.
Published: (2020-11-01) -
Metformin attenuates brain damage in mouse model of lipopolysaccharide-induced sepsis
by: TIAN Jing, et al.
Published: (2019-08-01) -
Intracellular and Extracellular Lipopolysaccharide Signaling in Sepsis: Avenues for Novel Therapeutic Strategies
by: Ramy S. Gabarin, et al.
Published: (2021-05-01) -
The Link between Obesity, Microbiota Dysbiosis, and Neurodegenerative Pathogenesis
by: Emanuel Vamanu, et al.
Published: (2021-06-01)